AGIOS PHARMACEUTICALS

Lobbying client · Massachusetts · filed 2025 to 2026

Pharmacy, Medicare/Medicaid, Health Issues

$150,000 Reported spend

6 Filings counted

1 Firms hired

0 Bills named

Spend is reported income plus in-house expenses across 6 filings. Everything on this page is grouped by the client's LDA id (67079), not by name.

Firms hired 1

AGIOS PHARMACEUTICALS $150,000 6 filings

Reported by year 2 years

2026 $100,000 2 filings
2025 $50,000 4 filings

Issues lobbied 4

Health Issues 6
Medicare/Medicaid 6
Medical/Disease Research/Clinical Labs 4
Pharmacy 2

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 2

HOUSE OF REPRESENTATIVES 5
SENATE 5

Recent filings 6 total

Q2

AGIOS PHARMACEUTICALS

2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $30,000 expenses · posted Jul 20, 2026

View → Q1

AGIOS PHARMACEUTICALS

1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · $70,000 expenses · posted Apr 17, 2026

View → Q4

AGIOS PHARMACEUTICALS

4th Quarter (Oct 1 - Dec 31) 2025 · House · Senate · $20,000 expenses · posted Jan 20, 2026

View → Q3

AGIOS PHARMACEUTICALS

3rd Quarter (July 1 - Sep 30) 2025 · House · Senate · $10,000 expenses · posted Oct 17, 2025

View → 2A

AGIOS PHARMACEUTICALS

2nd Quarter (Apr 1 - June 30) 2025 · House · Senate · $20,000 expenses · posted Jul 22, 2025

View → RR

AGIOS PHARMACEUTICALS

2nd Quarter (Apr 1 - June 30) 2025 · posted Jun 12, 2025

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.